PMC9427696

There was a weak negative correlation between pre-donation anxiety and PBSC stem cell yield in related donors, though this did not meet the study's pre-specified significance threshold of p=0.01.

Effect: null; r=−0.29

There was a weak negative correlation between pre-donation anxiety and PBSC stem cell yield in related donors, though this did not meet the study's pre-specified significance threshold of p=0.01.

Effect: null; r=−0.29

There was a weak negative correlation between pre-donation anxiety and PBSC stem cell yield in related donors, though this did not meet the study's pre-specified significance threshold of p=0.01.

Effect: null; r=−0.29

There was a weak negative correlation between pre-donation anxiety and PBSC stem cell yield in related donors, though this did not meet the study's pre-specified significance threshold of p=0.01.

Effect: null; r=−0.29

There was a weak negative correlation between pre-donation anxiety and PBSC stem cell yield in related donors, though this did not meet the study's pre-specified significance threshold of p=0.01.

Effect: null; r=−0.29

There was a weak negative correlation between pre-donation anxiety and PBSC stem cell yield in related donors, though this did not meet the study's pre-specified significance threshold of p=0.01.

Effect: null; r=−0.29

There was a weak negative correlation between pre-donation anxiety and PBSC stem cell yield in related donors, though this did not meet the study's pre-specified significance threshold of p=0.01.

Effect: null; r=−0.29

There was a weak negative correlation between pre-donation anxiety and PBSC stem cell yield in related donors, though this did not meet the study's pre-specified significance threshold of p=0.01.

Effect: null; r=−0.29

There was a weak negative correlation between pre-donation anxiety and PBSC stem cell yield in related donors, though this did not meet the study's pre-specified significance threshold of p=0.01.

Effect: null; r=−0.29

There was a weak negative correlation between pre-donation anxiety and PBSC stem cell yield in related donors, though this did not meet the study's pre-specified significance threshold of p=0.01.

Effect: null; r=−0.29

There was a weak negative correlation between pre-donation anxiety and PBSC stem cell yield in related donors, though this did not meet the study's pre-specified significance threshold of p=0.01.

Effect: null; r=−0.29

There was a weak negative correlation between pre-donation anxiety and PBSC stem cell yield in related donors, though this did not meet the study's pre-specified significance threshold of p=0.01.

Effect: null; r=−0.29

There was a weak negative correlation between pre-donation anxiety and PBSC stem cell yield in related donors, though this did not meet the study's pre-specified significance threshold of p=0.01.

Effect: null; r=−0.29

There was a weak negative correlation between pre-donation anxiety and PBSC stem cell yield in related donors, though this did not meet the study's pre-specified significance threshold of p=0.01.

Effect: null; r=−0.29

There was a weak negative correlation between pre-donation anxiety and PBSC stem cell yield in related donors, though this did not meet the study's pre-specified significance threshold of p=0.01.

Effect: null; r=−0.29

There was a weak negative correlation between pre-donation anxiety and PBSC stem cell yield in related donors, though this did not meet the study's pre-specified significance threshold of p=0.01.

Effect: null; r=−0.29

There was a weak negative correlation between pre-donation anxiety and PBSC stem cell yield in related donors, though this did not meet the study's pre-specified significance threshold of p=0.01.

Effect: null; r=−0.29

There was a weak negative correlation between pre-donation anxiety and PBSC stem cell yield in related donors, though this did not meet the study's pre-specified significance threshold of p=0.01.

Effect: null; r=−0.29

There was a weak negative correlation between pre-donation anxiety and PBSC stem cell yield in related donors, though this did not meet the study's pre-specified significance threshold of p=0.01.

Effect: null; r=−0.29

There was a weak negative correlation between pre-donation anxiety and PBSC stem cell yield in related donors, though this did not meet the study's pre-specified significance threshold of p=0.01.

Effect: null; r=−0.29

There was a weak negative correlation between pre-donation anxiety and PBSC stem cell yield in related donors, though this did not meet the study's pre-specified significance threshold of p=0.01.

Effect: null; r=−0.29

There was a weak negative correlation between pre-donation anxiety and PBSC stem cell yield in related donors, though this did not meet the study's pre-specified significance threshold of p=0.01.

Effect: null; r=−0.29

There was a weak negative correlation between pre-donation anxiety and PBSC stem cell yield in related donors, though this did not meet the study's pre-specified significance threshold of p=0.01.

Effect: null; r=−0.29

There was a weak negative correlation between pre-donation anxiety and PBSC stem cell yield in related donors, though this did not meet the study's pre-specified significance threshold of p=0.01.

Effect: null; r=−0.29

There was a weak negative correlation between pre-donation anxiety and PBSC stem cell yield in related donors, though this did not meet the study's pre-specified significance threshold of p=0.01.

Effect: null; r=−0.29

There was a weak negative correlation between pre-donation anxiety and PBSC stem cell yield in related donors, though this did not meet the study's pre-specified significance threshold of p=0.01.

Effect: null; r=−0.29

There was a weak negative correlation between pre-donation anxiety and PBSC stem cell yield in related donors, though this did not meet the study's pre-specified significance threshold of p=0.01.

Effect: null; r=−0.29

Related PBSC donors with pre-donation PCS scores in the highest quartile were significantly less likely to report grade 2-4 pain at 1 month post-donation compared with donors with PCS scores in the lo

Effect: decline; OR 0.1; CI: 95% CI 0.01-0.83

Related PBSC donors with pre-donation PCS scores in the highest quartile were significantly less likely to report grade 2-4 pain at 1 month post-donation compared with donors with PCS scores in the lo

Effect: decline; OR 0.1; CI: 95% CI 0.01-0.83

Related PBSC donors with pre-donation PCS scores in the highest quartile were significantly less likely to report grade 2-4 pain at 1 month post-donation compared with donors with PCS scores in the lo

Effect: decline; OR 0.1; CI: 95% CI 0.01-0.83

Related PBSC donors with pre-donation PCS scores in the highest quartile were significantly less likely to report grade 2-4 pain at 1 month post-donation compared with donors with PCS scores in the lo

Effect: decline; OR 0.1; CI: 95% CI 0.01-0.83

Related PBSC donors with pre-donation PCS scores in the highest quartile were significantly less likely to report grade 2-4 pain at 1 month post-donation compared with donors with PCS scores in the lo

Effect: decline; OR 0.1; CI: 95% CI 0.01-0.83

Related PBSC donors with pre-donation PCS scores in the highest quartile were significantly less likely to report grade 2-4 pain at 1 month post-donation compared with donors with PCS scores in the lo

Effect: decline; OR 0.1; CI: 95% CI 0.01-0.83

Related PBSC donors with pre-donation PCS scores in the highest quartile were significantly less likely to report grade 2-4 pain at 1 month post-donation compared with donors with PCS scores in the lo

Effect: decline; OR 0.1; CI: 95% CI 0.01-0.83

Related PBSC donors with pre-donation PCS scores in the highest quartile were significantly less likely to report grade 2-4 pain at 1 month post-donation compared with donors with PCS scores in the lo

Effect: decline; OR 0.1; CI: 95% CI 0.01-0.83

Related PBSC donors with pre-donation PCS scores in the highest quartile were significantly less likely to report grade 2-4 pain at 1 month post-donation compared with donors with PCS scores in the lo

Effect: decline; OR 0.1; CI: 95% CI 0.01-0.83

Related PBSC donors with pre-donation PCS scores in the highest quartile were significantly less likely to report grade 2-4 pain at 1 month post-donation compared with donors with PCS scores in the lo

Effect: decline; OR 0.1; CI: 95% CI 0.01-0.83

Related PBSC donors with pre-donation PCS scores in the highest quartile were significantly less likely to report grade 2-4 pain at 1 month post-donation compared with donors with PCS scores in the lo

Effect: decline; OR 0.1; CI: 95% CI 0.01-0.83

Related PBSC donors with pre-donation PCS scores in the highest quartile were significantly less likely to report grade 2-4 pain at 1 month post-donation compared with donors with PCS scores in the lo

Effect: decline; OR 0.1; CI: 95% CI 0.01-0.83

Related PBSC donors with pre-donation PCS scores in the highest quartile were significantly less likely to report grade 2-4 pain at 1 month post-donation compared with donors with PCS scores in the lo

Effect: decline; OR 0.1; CI: 95% CI 0.01-0.83

Related PBSC donors with pre-donation PCS scores in the highest quartile were significantly less likely to report grade 2-4 pain at 1 month post-donation compared with donors with PCS scores in the lo

Effect: decline; OR 0.1; CI: 95% CI 0.01-0.83

Related PBSC donors with pre-donation PCS scores in the highest quartile were significantly less likely to report grade 2-4 pain at 1 month post-donation compared with donors with PCS scores in the lo

Effect: decline; OR 0.1; CI: 95% CI 0.01-0.83

Related PBSC donors with pre-donation PCS scores in the highest quartile were significantly less likely to report grade 2-4 pain at 1 month post-donation compared with donors with PCS scores in the lo

Effect: decline; OR 0.1; CI: 95% CI 0.01-0.83

Related PBSC donors with pre-donation PCS scores in the highest quartile were significantly less likely to report grade 2-4 pain at 1 month post-donation compared with donors with PCS scores in the lo

Effect: decline; OR 0.1; CI: 95% CI 0.01-0.83

Related PBSC donors with pre-donation PCS scores in the highest quartile were significantly less likely to report grade 2-4 pain at 1 month post-donation compared with donors with PCS scores in the lo

Effect: decline; OR 0.1; CI: 95% CI 0.01-0.83

Related PBSC donors with pre-donation PCS scores in the highest quartile were significantly less likely to report grade 2-4 pain at 1 month post-donation compared with donors with PCS scores in the lo

Effect: decline; OR 0.1; CI: 95% CI 0.01-0.83

Related PBSC donors with pre-donation PCS scores in the highest quartile were significantly less likely to report grade 2-4 pain at 1 month post-donation compared with donors with PCS scores in the lo

Effect: decline; OR 0.1; CI: 95% CI 0.01-0.83

Related PBSC donors with pre-donation PCS scores in the highest quartile were significantly less likely to report grade 2-4 pain at 1 month post-donation compared with donors with PCS scores in the lo

Effect: decline; OR 0.1; CI: 95% CI 0.01-0.83

Related PBSC donors with pre-donation PCS scores in the highest quartile were significantly less likely to report grade 2-4 pain at 1 month post-donation compared with donors with PCS scores in the lo

Effect: decline; OR 0.1; CI: 95% CI 0.01-0.83

Related PBSC donors with pre-donation PCS scores in the highest quartile were significantly less likely to report grade 2-4 pain at 1 month post-donation compared with donors with PCS scores in the lo

Effect: decline; OR 0.1; CI: 95% CI 0.01-0.83